Cargando…
Advances in molecular, genetic and immune signatures of gastric cancer: Are we ready to apply them in our patients’ decision making?
In the last few years we have witnessed a vast expansion of our knowledge regarding the molecular and genetic profile of gastric cancer. The molecular subtypes described have shed light on the pathogenesis of the disease, thus prompting the development of new therapeutic strategies and favoring a mo...
Autores principales: | Gkolfinopoulos, Stavros, Papamichael, Demetris, Papadimitriou, Konstantinos, Papanastasopoulos, Panos, Vassiliou, Vassilios, Kountourakis, Panteleimon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6068857/ https://www.ncbi.nlm.nih.gov/pubmed/30079143 http://dx.doi.org/10.4251/wjgo.v10.i7.172 |
Ejemplares similares
-
Chromogranin A as a valid marker in oncology: Clinical application or false hopes?
por: Gkolfinopoulos, Stavros, et al.
Publicado: (2017) -
Adjuvant Chemoradiation Therapy in Gastric Cancer: Critically Reviewing the Past and Visualizing the Next Step Forward
por: Papadimitriou, Konstantinos, et al.
Publicado: (2015) -
Outcomes of 556 consecutive patients with stage I-III colon cancer managed in a single center over 10 years
por: Xenophontos, Eleni, et al.
Publicado: (2021) -
Leptomeningeal metastases originated from esophagogastric junction/gastric cancer: A brief report of two cases
por: Kountourakis, Panteleimon, et al.
Publicado: (2018) -
Bilateral De Quervain Syndrome after Aromatase Inhibitor Administration: A Case Report and Review of the Literature
por: Papadimitriou, Konstantinos, et al.
Publicado: (2012)